Stephen S. Yoder
2018
In 2018, Stephen S. Yoder earned a total compensation of $2.6M as Chief Executive Officer at Pieris Pharmaceuticals, a 110% increase compared to previous year.
Compensation breakdown
| Bonus | $212,500 |
|---|---|
| Option Awards | $1,866,366 |
| Salary | $500,000 |
| Other | $42,142 |
| Total | $2,621,008 |
Yoder received $1.9M in option awards, accounting for 71% of the total pay in 2018.
Yoder also received $212.5K in bonus, $500K in salary and $42.1K in other compensation.
Rankings
In 2018, Stephen S. Yoder's compensation ranked 4,454th out of 14,244 executives tracked by ExecPay. In other words, Yoder earned more than 68.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,454 out of 14,244 | 69th |
Division Manufacturing | 1,667 out of 5,762 | 71st |
Major group Chemicals And Allied Products | 598 out of 2,125 | 72nd |
Industry group Drugs | 499 out of 1,814 | 73rd |
Industry Pharmaceutical Preparations | 388 out of 1,388 | 72nd |
Source: SEC filing on June 18, 2019.
Yoder's colleagues
We found two more compensation records of executives who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2018.